查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1489204

全球去氧肾上腺素药物市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Phenylephrine Drugs Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 177 Pages | 商品交期: 最快1-2个工作天内

价格

全球去氧肾上腺素药物市场需求预计将从 2023 年的 220.5 亿美元达到 2032 年近 406.1 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 7.02%。

去氧肾上腺素药物是一类用于缓解鼻塞和鼻窦压力的药物，这些鼻塞和鼻窦压力与普通感冒、过敏和鼻窦炎等疾病有关。它们收缩鼻道中的血管，减少肿胀和充血并促进呼吸。这些药物有多种剂型，包括鼻喷剂、口服片剂和眼药水，提供了给药和剂量的灵活性。虽然按照指示使用通常被认为是安全有效的，但这些药物可能会导致某些人血压升高、心跳加速和头痛。它们常见于非处方感冒药和过敏药中，可缓解鼻塞和相关症状。

市场动态

全球鼻塞、鼻窦炎和过敏性鼻炎的盛行率不断上升，加上感冒、流感和呼吸道感染发病率的上升，推动了对基于去氧肾上腺素的减充血剂作为非处方药和处方药的需求。当人们寻求缓解鼻塞和相关症状时，去氧肾上腺素药物可以透过缩小鼻道血管并减少肿胀和充血来快速有效地缓解症状。此外，药物配方、输送系统和联合疗法的进步推动了去氧肾上腺素药物的创新，从而能够开发缓释製剂、多症状缓解产品和儿科友好剂型，以满足不同患者的需求。

此外，去氧肾上腺素药物在眼用溶液、口服药物和心血管支持注射製剂中的不断扩大应用正在推动市场成长和多样化。此外，随着消费者寻求方便易用的解决方案来在家中控制感冒和过敏症状，对自我照顾、健康和预防性医疗保健的日益关注推动了对非处方去氧肾上腺素产品的需求。然而，替代性减充血药物的出现以及鼻塞非药物治疗的出现可能会对未来几年的市场成长构成挑战。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球去氧肾上腺素药物市场的每个细分市场进行了包容性评估。去氧肾上腺素药物产业的成长和趋势为本研究提供了整体方法。

市场区隔

去氧肾上腺素药物市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

依产品类型

  • 平板电脑
  • 糖浆
  • 眼药水
  • 其他

依给药途径

  • 口服
  • 注射用
  • 其他

按指示

  • 寒冷的
  • 鼻充血缓解术
  • 过敏反应
  • 眼部疾病
  • 其他

按配销通路

  • 医院药房
  • 药局和零售药局
  • 网路药局

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲去氧肾上腺素药物市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。去氧肾上腺素药物市场的主要参与者包括诺华公司、Perrigo Company PLC、强生消费品公司（Kenvue Inc.）、宝洁公司、辉瑞公司、Foundation Consumer Brands LLC、Mylan NV、Torrent Pharmaceuticals Inc.。克公司、拜耳公司。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：去氧肾上腺素药物 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 市场吸引力分析：按产品类型
    • 按给药途径进行的市场吸引力分析
    • 按指标进行的市场吸引力分析
    • 按配销通路分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球去氧肾上腺素药物市场分析：依产品类型

  • 概述：按产品类型
  • 历史和预测数据
  • 分析：依产品类型
  • 平板电脑
  • 糖浆
  • 眼药水
  • 其他

第 6 章：全球去氧肾上腺素药物市场分析：依给药途径

  • 依给药途径概述
  • 历史和预测数据
  • 依给药途径分析
  • 口服
  • 注射用
  • 其他

第 7 章：全球去氧肾上腺素药物市场分析：依适应症分类

  • 按指示概述
  • 历史和预测数据
  • 按指标分析
  • 寒冷的
  • 鼻充血缓解术
  • 过敏反应
  • 眼部疾病
  • 其他

第 8 章：全球去氧肾上腺素药物市场分析：按分销管道

  • 配销通路概述
  • 历史和预测数据
  • 按配销通路分析
  • 医院药房
  • 药局和零售药局
  • 网路药局

第 9 章：全球去氧肾上腺素药物市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 10 章：去氧肾上腺素药品公司的竞争格局

  • 去氧肾上腺素药物市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 11 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Novartis AG
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Perrigo Company PLC
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Johnson & Johnson Consumer Inc. (Kenvue Inc.)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Proctor & Gamble Co.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Pfizer Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Foundation Consumer Brands LLC
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Mylan NV
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Torrent Pharmaceuticals Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • GlaxoSmithKline PLC
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Bayer AG
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR112114533

The global demand for Phenylephrine Drugs Market is presumed to reach the market size of nearly USD 40.61 Billion by 2032 from USD 22.05 Billion in 2023 with a CAGR of 7.02% under the study period 2024-2032.

Phenylephrine drugs are a class of medications employed to alleviate nasal congestion and sinus pressure linked with conditions like the common cold, allergies, and sinusitis. They constrict blood vessels in the nasal passages, reducing swelling and congestion and facilitating easier breathing. These drugs are available in various formulations, including nasal sprays, oral tablets, and eye drops, providing flexibility in administration and dosage. Though generally regarded as safe and effective when used according to instructions, these drugs may cause elevated blood pressure, rapid heartbeat, and headache in some individuals. They are commonly found in over-the-counter cold and allergy medications, relieving nasal congestion and related symptoms.

MARKET DYNAMICS

The increasing prevalence of nasal congestion, sinusitis, and allergic rhinitis worldwide, coupled with the rising incidence of colds, flu, and respiratory infections, drives demand for phenylephrine-based decongestants as over-the-counter and prescription medications. As individuals seek relief from nasal congestion and related symptoms, phenylephrine drugs offer rapid and effective relief by narrowing nasal passages blood vessels and reducing swelling and congestion. Additionally, advancements in drug formulations, delivery systems, and combination therapies drive innovation in phenylephrine drugs, enabling the development of extended-release formulations, multi-symptom relief products, and pediatric-friendly dosage forms to meet diverse patient needs.

Furthermore, the expanding applications of phenylephrine drugs in ophthalmic solutions, oral medications, and injectable formulations for cardiovascular support are driving market growth and diversification. Moreover, the increasing focus on self-care, wellness, and preventive healthcare drives demand for over-the-counter phenylephrine products as consumers seek convenient and accessible solutions for managing cold and allergy symptoms at home. However, the availability of alternative decongestant medications and the emergence of non-pharmacological treatments for nasal congestion may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Phenylephrine Drugs. The growth and trends of Phenylephrine Drugs industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Phenylephrine Drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Tablets
  • Syrups
  • Eye Drops
  • Other

By Route Of Administration

  • Oral
  • Parenteral
  • Other

By Indication

  • Cold
  • Nasal Decongestion
  • Allergic Reaction
  • Eye Disease
  • Other

By Distribution Channel

  • Hospital Pharmacies
  • Drug Stores & Retail Pharmacies
  • Online Pharmacies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Phenylephrine Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Phenylephrine Drugs market include Novartis AG, Perrigo Company PLC, Johnson & Johnson Consumer Inc. (Kenvue Inc.), Proctor & Gamble Co., Pfizer Inc., Foundation Consumer Brands LLC, Mylan N.V., Torrent Pharmaceuticals Inc., GlaxoSmithKline PLC, Bayer AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. PHENYLEPHRINE DRUGS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Route Of Administration
    • 3.7.3 Market Attractiveness Analysis By Indication
    • 3.7.4 Market Attractiveness Analysis By Distribution Channel
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL PHENYLEPHRINE DRUGS MARKET ANALYSIS BY PRODUCT TYPE

  • 5.1. Overview By Product Type
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Product Type
  • 5.4. Tablets Historic and Forecast Sales By Regions
  • 5.5. Syrups Historic and Forecast Sales By Regions
  • 5.6. Eye Drops Historic and Forecast Sales By Regions
  • 5.7. Other Historic and Forecast Sales By Regions

6. GLOBAL PHENYLEPHRINE DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 6.1. Overview By Route Of Administration
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Route Of Administration
  • 6.4. Oral Historic and Forecast Sales By Regions
  • 6.5. Parenteral Historic and Forecast Sales By Regions
  • 6.6. Other Historic and Forecast Sales By Regions

7. GLOBAL PHENYLEPHRINE DRUGS MARKET ANALYSIS BY INDICATION

  • 7.1. Overview By Indication
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Indication
  • 7.4. Cold Historic and Forecast Sales By Regions
  • 7.5. Nasal Decongestion Historic and Forecast Sales By Regions
  • 7.6. Allergic Reaction Historic and Forecast Sales By Regions
  • 7.7. Eye Disease Historic and Forecast Sales By Regions
  • 7.8. Other Historic and Forecast Sales By Regions

8. GLOBAL PHENYLEPHRINE DRUGS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 8.1. Overview By Distribution Channel
  • 8.2. Historical and Forecast Data
  • 8.3. Analysis By Distribution Channel
  • 8.4. Hospital Pharmacies Historic and Forecast Sales By Regions
  • 8.5. Drug Stores & Retail Pharmacies Historic and Forecast Sales By Regions
  • 8.6. Online Pharmacies Historic and Forecast Sales By Regions

9. GLOBAL PHENYLEPHRINE DRUGS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE PHENYLEPHRINE DRUGS COMPANIES

  • 10.1. Phenylephrine Drugs Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF PHENYLEPHRINE DRUGS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Novartis AG
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Perrigo Company PLC
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Johnson & Johnson Consumer Inc. (Kenvue Inc.)
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Proctor & Gamble Co.
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Pfizer Inc.
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Foundation Consumer Brands LLC
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Mylan N.V.
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Torrent Pharmaceuticals Inc.
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. GlaxoSmithKline PLC
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Bayer AG
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product Type (USD MN)
  • Tablets Market Sales By Geography (USD MN)
  • Syrups Market Sales By Geography (USD MN)
  • Eye Drops Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Analysis By Route Of Administration (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Parenteral Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Analysis By Indication (USD MN)
  • Cold Market Sales By Geography (USD MN)
  • Nasal Decongestion Market Sales By Geography (USD MN)
  • Allergic Reaction Market Sales By Geography (USD MN)
  • Eye Disease Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Drug Stores & Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Global Phenylephrine Drugs Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Phenylephrine Drugs Report
  • Market Research Process
  • Market Research Methodology
  • Global Phenylephrine Drugs Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product Type
  • Market Attractiveness Analysis By Route Of Administration
  • Market Attractiveness Analysis By Indication
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product Type (USD MN)
  • Tablets Market Sales By Geography (USD MN)
  • Syrups Market Sales By Geography (USD MN)
  • Eye Drops Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global Market Analysis By Route Of Administration (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Parenteral Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global Market Analysis By Indication (USD MN)
  • Cold Market Sales By Geography (USD MN)
  • Nasal Decongestion Market Sales By Geography (USD MN)
  • Allergic Reaction Market Sales By Geography (USD MN)
  • Eye Disease Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Drug Stores & Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.